DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Vfend (Voriconazole) - Life Threatening Events - Suspected Cause - Side Effect Reports

 
 



Index of reports > Life Threatening Events (51)

Below is the selection of side effect reports (a.k.a. adverse event reports) related to Vfend (Voriconazole) life threatening events. The selected reports were submitted to the FDA during the sample period of about a year.

 Reports 1 - 30 of 51   Next >>

Possible Vfend side effects in 65 year old female

Reported by a physician from Japan on 2012-08-24

Patient: 65 year old female, weighing 57.0 kg (125.4 pounds)

Reactions: Bronchopulmonary Aspergillosis, Drug Interaction, Anaemia Macrocytic, Hypertriglyceridaemia

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Vfend

Other drugs received by patient possibly interacting with the suspect drug:
Lipitor
    Dosage: 10 mg, 1x/day
    Administration route: Oral
    Start date: 2011-10-19
    End date: 2012-02-15

Other drugs received by patient: Neoral; Basen; Sulfamethoxazole and Trimethoprim; Prednisolone; Bonalen(alendronate Sodium); Fungizone; Lansoprazole; Candesartan Cilexetil; Metformin HCL



Possible Vfend side effects in 82 year old male

Reported by a physician from Japan on 2012-08-17

Patient: 82 year old male, weighing 50.3 kg (110.7 pounds)

Reactions: Photosensitivity Reaction, Squamous Cell Carcinoma

Adverse event resulted in: life threatening event

Drug(s) suspected as cause:
Tamsulosin HCL
    Dosage: 0.2 mg, 1x/day
    Start date: 2006-11-08
    End date: 2007-03-08

Vfend
    Dosage: 200 mg, 3x/day
    Administration route: Oral
    Indication: Bronchopulmonary Aspergillosis
    Start date: 2006-08-30
    End date: 2011-11-07

Vfend
    Dosage: unk
    Administration route: Oral
    Start date: 2011-01-01
    End date: 2011-11-01

Other drugs received by patient: Amlodipine; Trichlormethiazide; Ludiomil; Atarax; Amitriptyline HCL; Ferrous Fumarate; Clarithromycin; Blostar M



Possible Vfend side effects in female

Reported by a physician from France on 2012-08-02

Patient: female, weighing 75.0 kg (165.0 pounds)

Reactions: Hepatitis Acute, Lobar Pneumonia

Adverse event resulted in: death, life threatening event, hospitalization

Drug(s) suspected as cause:
Vfend
    Dosage: 400 milligram
    Administration route: Oral
    Indication: Prophylaxis
    Start date: 2012-03-06
    End date: 2012-07-17

Revlimid
    Administration route: Oral
    Start date: 2012-04-13

Revlimid
    Dosage: 25 milligram
    Administration route: Oral
    Start date: 2012-07-06
    End date: 2012-07-17

Atovaquone
    Dosage: 1.5 gram
    Administration route: Oral
    Indication: Prophylaxis
    Start date: 2012-03-15
    End date: 2012-07-17

Other drugs received by patient: RED Blood Cells; Dexamethasone



Possible Vfend side effects in 42 year old male

Reported by a physician from Switzerland on 2012-06-14

Patient: 42 year old male

Reactions: Cholelithiasis, Shock Haemorrhagic, Cholangitis Acute

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Vfend
    Dosage: 350 mg, 2x/day
    Administration route: Oral
    Indication: Bronchopulmonary Aspergillosis
    Start date: 2012-01-17
    End date: 2012-04-11

Bactrim
    Dosage: 160 mg, three per one week
    Administration route: Oral
    Start date: 2011-12-01

Other drugs received by patient: Ciprofloxacin; Codeine; Prednisone



Possible Vfend side effects in 45 year old female

Reported by a health professional (non-physician/pharmacist) from France on 2012-05-23

Patient: 45 year old female, weighing 60.0 kg (132.0 pounds)

Reactions: Confusional State, Dyskinesia, Hypotonia, Altered State of Consciousness

Adverse event resulted in: life threatening event

Drug(s) suspected as cause:
Fludarabine Phosphate
    Dosage: 68 mg, unk
    Indication: Cord Blood Transplant Therapy
    Start date: 2012-01-05
    End date: 2012-01-08

Cyclophosphamide
    Dosage: 1905 mg, unk
    Indication: Cord Blood Transplant Therapy
    Start date: 2012-01-05
    End date: 2012-01-06

Thymoglobulin
    Dosage: 476 mg, unk
    Indication: Cord Blood Transplant Therapy
    Start date: 2012-01-09
    End date: 2012-01-10

Neoral
    Dosage: unk
    Start date: 2011-10-29
    End date: 2012-01-15

Targocid
    Dosage: 400 mg, 1x/day
    Start date: 2011-12-27
    End date: 2012-01-15

Vfend
    Dosage: 400 mg, 1x/day
    Indication: Candidiasis
    Start date: 2011-12-30
    End date: 2012-01-15

Cefepime
    Dosage: 6 g, 1x/day
    Indication: Cord Blood Transplant Therapy
    Start date: 2011-12-30
    End date: 2012-01-15



Possible Vfend side effects in 43 year old male

Reported by a health professional (non-physician/pharmacist) from France on 2012-05-22

Patient: 43 year old male, weighing 70.0 kg (154.0 pounds)

Reactions: Cholecystitis, Pyrexia, Escherichia Sepsis

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Methadone
    Dosage: 60 mg, 1x/day
    Administration route: Oral
    Indication: Drug Dependence
    Start date: 2011-03-01

Vfend
    Dosage: 200 mg, 2x/day
    Administration route: Oral
    Indication: Meningitis Candida
    Start date: 2011-10-21

Acetaminophen and Tramadol HCL
    Dosage: 2 df, 3x/day
    Administration route: Oral
    Indication: Pain
    Start date: 2011-08-16

Other drugs received by patient: Trimeprazine Tartrate; Imovane; Cacit D3; Atarax; Prednisone TAB; Potassium Chloride



Possible Vfend side effects in 50 year old female

Reported by a health professional (non-physician/pharmacist) from France on 2012-05-21

Patient: 50 year old female, weighing 45.6 kg (100.3 pounds)

Reactions: Posterior Reversible Encephalopathy Syndrome

Adverse event resulted in: life threatening event

Drug(s) suspected as cause:
Cyclosporine
    Dosage: unk
    Indication: Immunosuppression
    Start date: 2011-10-24
    End date: 2011-11-09

Eprex
    Dosage: 8000 iu, 3x/week
    Indication: Anaemia
    Start date: 2011-10-24

Vfend
    Dosage: 400 mg, 2x/day
    Indication: Infection
    Start date: 2011-10-24

Cellcept
    Dosage: 1 g, 2x/day
    Indication: Immunosuppression
    Start date: 2011-10-24

Invanz
    Dosage: unk
    Indication: Infection
    Start date: 2011-11-10
    End date: 2011-11-14

Prograf
    Dosage: unk
    Indication: Immunosuppression
    Start date: 2011-11-07
    End date: 2011-11-16

Cyclosporine
    Dosage: unk
    Start date: 2011-11-16

Other drugs received by patient: Acetaminophen; Atrovent; Bricanyl; Prednisone TAB; Lasix; Valacyclovir Hydrochloride; Calcium Folinate; Umuline; Nexium



Possible Vfend side effects in 43 year old male

Reported by a health professional (non-physician/pharmacist) from France on 2012-05-21

Patient: 43 year old male, weighing 70.0 kg (154.0 pounds)

Reactions: Pyrexia, Cholecystitis, Escherichia Sepsis

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Acetaminophen and Tramadol HCL
    Dosage: 2 df, 3x/day
    Administration route: Oral
    Indication: Pain
    Start date: 2011-08-16

Vfend
    Dosage: 200 mg, 2x/day
    Administration route: Oral
    Indication: Meningitis Candida
    Start date: 2011-10-21

Methadone
    Dosage: 60 mg, 1x/day
    Administration route: Oral
    Indication: Drug Dependence
    Start date: 2011-03-01

Other drugs received by patient: Prednisone TAB; Trimeprazine Tartrate; Potassium Chloride; Cacit D3; Imovane; Atarax



Possible Vfend side effects in 62 year old female

Reported by a health professional (non-physician/pharmacist) from France on 2012-05-21

Patient: 62 year old female, weighing 50.0 kg (110.0 pounds)

Reactions: Malaise, Presyncope, Disturbance in Attention, Hallucination, Loss of Consciousness

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Vfend

Other drugs received by patient: Bactrim; Certican; Vitamin B1 and B6; Cancidas; Zovirax; Vitabact; Prednisone TAB; Calcium Carbonate; Potassium Chloride; Folic Acid; Rocephin; Ciprofloxacin Hydrochloride; Ciclosporin; Midazolam; Atorvastatin; Solu-Medrol; Sufentanil



Possible Vfend side effects in 44 year old female

Reported by a health professional (non-physician/pharmacist) from France on 2012-05-21

Patient: 44 year old female, weighing 50.0 kg (110.0 pounds)

Reactions: Renal Failure

Adverse event resulted in: death, life threatening event, hospitalization

Drug(s) suspected as cause:
Vfend

Other drugs received by patient: Tazobactam; Ciprofloxacin Hydrochloride; Cancidas; Zyvox



Possible Vfend side effects in 43 year old male

Reported by a health professional (non-physician/pharmacist) from France on 2012-05-17

Patient: 43 year old male

Reactions: Cholecystitis, Pyrexia, Escherichia Sepsis

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Methadone HCL
    Dosage: 60 mg, 1x/day
    Administration route: Oral
    Indication: Drug Dependence
    Start date: 2011-03-01

Vfend
    Dosage: 200 mg, 2x/day
    Administration route: Oral
    Indication: Meningitis Candida
    Start date: 2011-10-21

Acetaminophen and Tramadol HCL
    Dosage: 2 df, 3x/day
    Administration route: Oral
    Indication: Pain
    Start date: 2011-08-16

Other drugs received by patient: Potassium Chloride; Prednisone TAB; Imovane; Cacit D3; Trimeprazine Tartrate; Atarax



Possible Vfend side effects in male

Reported by a health professional (non-physician/pharmacist) from France on 2012-05-16

Patient: male

Reactions: Cholecystitis, Pyrexia, Escherichia Sepsis

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Methadone HCL
    Administration route: Oral
    Indication: Drug Dependence
    Start date: 2011-03-01

Vfend
    Administration route: Oral
    Indication: Meningitis Candida
    Start date: 2011-10-21

Acetaminophen and Tramadol HCL
    Administration route: Oral
    Indication: Pain
    Start date: 2011-08-16

Other drugs received by patient: Cacit NOS; Trimeprazine Tartrate; Atarax; Prednisone TAB; Imovane; Potassium Chloride



Possible Vfend side effects in female

Reported by a health professional (non-physician/pharmacist) from France on 2012-05-16

Patient: female

Reactions: Confusional State, Dyskinesia, Hypotonia, Altered State of Consciousness

Adverse event resulted in: life threatening event

Drug(s) suspected as cause:
Neoral
    Start date: 2011-10-29
    End date: 2012-01-15

Fludarabine Phosphate
    Indication: Cord Blood Transplant Therapy
    Start date: 2012-01-05
    End date: 2012-01-08

Vfend
    Start date: 2011-12-30
    End date: 2012-01-15

Cyclophosphamide
    Indication: Cord Blood Transplant Therapy
    Start date: 2012-01-05
    End date: 2012-01-06

Thymoglobulin
    Indication: Cord Blood Transplant Therapy
    Start date: 2012-01-09
    End date: 2012-01-10

Cefepime
    Indication: Cord Blood Transplant Therapy
    Start date: 2011-12-30
    End date: 2012-01-15

Targocid
    Start date: 2011-12-27
    End date: 2012-01-15



Possible Vfend side effects in 42 year old male

Reported by a physician from Switzerland on 2012-05-15

Patient: 42 year old male

Reactions: Cholelithiasis, Shock Haemorrhagic, Cholangitis Acute

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Bactrim
    Dosage: 160 mg, three per one week
    Administration route: Oral
    Start date: 2011-12-01

Vfend
    Dosage: 350 mg, 2x/day
    Administration route: Oral
    Indication: Bronchopulmonary Aspergillosis
    Start date: 2012-01-17
    End date: 2012-04-11

Other drugs received by patient: Prednisone; Codeine; Ciprofloxacin



Possible Vfend side effects in male

Reported by a physician from Switzerland on 2012-04-26

Patient: male

Reactions: Blood Bilirubin Increased, Alanine Aminotransferase Increased, Coma Hepatic, Cholestasis, Hepatic Steatosis

Adverse event resulted in: death, life threatening event, hospitalization

Drug(s) suspected as cause:
Methotrexate Sodium
    Indication: Acute Lymphocytic Leukaemia
    Start date: 2005-02-09
    End date: 2005-03-07

Fungizone
    Indication: Aspergilloma
    Start date: 2005-02-01
    End date: 2005-02-01

Vfend
    Indication: Aspergilloma
    Start date: 2005-02-20
    End date: 2005-03-08

Vincristine Sulfate
    Indication: Acute Lymphocytic Leukaemia
    Start date: 2005-02-09
    End date: 2005-03-07

Methotrexate Sodium
    Indication: Acute Lymphocytic Leukaemia
    Start date: 2005-02-09
    End date: 2005-03-07

Asparaginase
    Indication: Acute Lymphocytic Leukaemia
    Start date: 2005-02-09
    End date: 2005-03-07

Tazobactam
    Indication: Aspergilloma
    Start date: 2005-02-12
    End date: 2005-03-04

Valtrex
    Indication: Aspergilloma
    Start date: 2005-02-20
    End date: 2005-03-08

Cyclophosphamide
    Indication: Acute Lymphocytic Leukaemia
    Start date: 2005-02-09
    End date: 2005-03-07

Other drugs received by patient: Navoban; Torsemide; Prednisone TAB; Bactrim



Possible Vfend side effects in 68 year old male

Reported by a physician from Switzerland on 2012-04-24

Patient: 68 year old male

Reactions: Bronchopulmonary Aspergillosis, Blood Bilirubin Increased, Alanine Aminotransferase Increased, Cholestasis, Cardiac Disorder, Hepatic Steatosis, Multi-Organ Failure, Hepatic Encephalopathy, Lower Gastrointestinal Haemorrhage, Upper Gastrointestinal Haemorrhage, Renal Failure Acute

Adverse event resulted in: death, life threatening event, hospitalization

Drug(s) suspected as cause:
Tazobactam
    Dosage: unk
    Indication: Aspergilloma
    Start date: 2005-02-12
    End date: 2005-03-04

Cerubidine
    Dosage: unknown
    Indication: Acute Lymphocytic Leukaemia
    Start date: 2005-02-09
    End date: 2005-03-07

Methotrexate Sodium
    Dosage: unknown
    Indication: Acute Lymphocytic Leukaemia
    Start date: 2005-02-09
    End date: 2005-03-07

Oncovin
    Dosage: unknown
    Indication: Acute Lymphocytic Leukaemia
    Start date: 2005-02-09
    End date: 2005-03-07

Cyclophosphamide
    Dosage: unknown
    Indication: Acute Lymphocytic Leukaemia
    Start date: 2005-02-09
    End date: 2005-03-07

Valtrex
    Dosage: unknown
    Indication: Aspergilloma
    Start date: 2005-02-20
    End date: 2005-03-08

Asparaginase
    Dosage: unknown
    Indication: Acute Lymphocytic Leukaemia
    Start date: 2005-02-09
    End date: 2005-03-07

Fungizone
    Dosage: unknown
    Indication: Aspergilloma
    Start date: 2005-02-01
    End date: 2005-02-01

Vfend
    Dosage: unk
    Indication: Aspergilloma
    Start date: 2005-02-20
    End date: 2005-03-08

Other drugs received by patient: Bactrim; Prednisone; Navoban; Torsemide



Possible Vfend side effects in male

Reported by a physician from Japan on 2012-04-24

Patient: male

Reactions: Hepatic Function Abnormal, Cardiomyopathy

Adverse event resulted in: life threatening event

Drug(s) suspected as cause:
Vfend



Possible Vfend side effects in 50 year old female

Reported by a health professional (non-physician/pharmacist) from France on 2012-04-20

Patient: 50 year old female

Reactions: Posterior Reversible Encephalopathy Syndrome, Convulsion

Adverse event resulted in: life threatening event

Drug(s) suspected as cause:
Vfend
    Indication: Immunosuppression
    Start date: 2011-10-24

Invanz
    Indication: Infection
    Start date: 2011-11-10
    End date: 2011-11-14

Eprex
    Indication: Anaemia
    Start date: 2011-10-24

Cyclosporine
    Indication: Immunosuppression
    Start date: 2011-10-24
    End date: 2011-11-09

Mycophenolate Mofetil (Cellcept)
    Indication: Immunosuppression
    Start date: 2011-10-24

Prograf
    Indication: Immunosuppression
    Start date: 2011-11-07
    End date: 2011-11-16

Other drugs received by patient: Folinoral; Bricanyl; Prednisone TAB; Nexium; Acetaminophen; Valacyclovir Hydrochloride; Umuline Rapide; Atrovent; Lasix



Possible Vfend side effects in female

Reported by a health professional (non-physician/pharmacist) from France on 2012-04-03

Patient: female

Reactions: Movement Disorder, Confusional State, Aphasia, Dyskinesia, Diplegia, Disorientation, Subdural Haemorrhage, Extensor Plantar Response, Fungaemia, Speech Disorder, Stem Cell Transplant, Dialysis, Hypotonia, Altered State of Consciousness

Adverse event resulted in: life threatening event

Drug(s) suspected as cause:
Vfend
    Dosage: 400 mg, qd
    Indication: Anti-Infective Therapy
    Start date: 2011-12-30
    End date: 2012-01-15

Fludarabine Phosphate
    Dosage: 68 mg, unk
    Indication: Bone Marrow Conditioning Regimen
    Start date: 2012-01-05
    End date: 2012-01-08

Targocid
    Dosage: 400 mg, unk
    Indication: Antibiotic Therapy
    Start date: 2011-12-27
    End date: 2012-01-15

Thymoglobulin
    Dosage: 476 mg, unk
    Indication: Bone Marrow Conditioning Regimen
    Start date: 2012-01-09
    End date: 2012-01-10

Neoral
    Dosage: unk
    Indication: Product Used FOR Unknown Indication
    Start date: 2011-10-29
    End date: 2012-01-15

Cyclophosphamide
    Dosage: 1905 mg, unk
    Indication: Bone Marrow Conditioning Regimen
    Start date: 2012-01-05
    End date: 2012-01-06

Cefepime
    Dosage: 6 g, unk
    Indication: Antibiotic Therapy
    Start date: 2011-12-30
    End date: 2012-01-15



Possible Vfend side effects in female

Reported by a health professional (non-physician/pharmacist) from France on 2012-04-03

Patient: female

Reactions: Confusional State, Neurological Decompensation, Diplegia, Aphasia, Dyskinesia, Coma Scale Abnormal, Disorientation, Extensor Plantar Response, Subdural Haemorrhage, Death, Speech Disorder, Hypotonia, Blood Creatinine Increased, Altered State of Consciousness

Adverse event resulted in: death, life threatening event

Drug(s) suspected as cause:
Anti-Thymocyte Globulin Rabbit NOS
    Dosage: unk ukn, unk
    Start date: 2012-01-09
    End date: 2012-01-10

Targocid
    Dosage: 400 mg, daily
    Start date: 2011-12-27
    End date: 2012-01-15

Fludarabine Phosphate
    Dosage: unk ukn, unk
    Indication: Stem Cell Transplant
    Start date: 2012-01-05
    End date: 2012-01-08

Vfend
    Dosage: 400 mg, daily
    Start date: 2011-12-30
    End date: 2012-01-15

Neoral
    Dosage: unk ukn, unk
    Start date: 2011-10-29
    End date: 2012-01-15

Cyclophosphamide
    Dosage: 1905 mg, unk
    Indication: Stem Cell Transplant
    Start date: 2012-01-05
    End date: 2012-01-06

Cefepime
    Dosage: 6 g, daily
    Indication: Stem Cell Transplant
    Start date: 2011-12-30
    End date: 2012-01-15

Other drugs received by patient: Antilymphocyte Serum; Corticosteroid NOS



Possible Vfend side effects in female

Reported by a health professional (non-physician/pharmacist) from France on 2012-04-03

Patient: female

Reactions: Confusional State, Neurological Decompensation, Aphasia, Dyskinesia, Diplegia, Disorientation, Coma Scale Abnormal, Subdural Haemorrhage, Extensor Plantar Response, Death, Speech Disorder, Hypotonia, Blood Creatinine Increased, Altered State of Consciousness

Adverse event resulted in: death, life threatening event

Drug(s) suspected as cause:
Cefepime
    Dosage: 6 g, daily
    Indication: Stem Cell Transplant
    Start date: 2011-12-30
    End date: 2012-01-15

Targocid
    Dosage: 400 mg, daily
    Start date: 2011-12-27
    End date: 2012-01-15

Neoral
    Dosage: unk ukn, unk
    Start date: 2011-10-29
    End date: 2012-01-15

Cyclophosphamide
    Dosage: 1905 mg, unk
    Indication: Stem Cell Transplant
    Start date: 2012-01-05
    End date: 2012-01-06

Anti-Thymocyte Globulin Rabbit NOS
    Dosage: unk ukn, unk
    Start date: 2012-01-09
    End date: 2012-01-10

Vfend
    Dosage: 400 mg, daily
    Start date: 2011-12-30
    End date: 2012-01-15

Fludarabine Phosphate
    Dosage: unk ukn, unk
    Indication: Stem Cell Transplant
    Start date: 2012-01-05
    End date: 2012-01-08

Other drugs received by patient: Corticosteroid NOS; Antilymphocyte Serum



Possible Vfend side effects in female

Reported by a health professional (non-physician/pharmacist) from France on 2012-04-02

Patient: female

Reactions: Confusional State, Dyskinesia, Hypotonia, Altered State of Consciousness

Adverse event resulted in: life threatening event

Drug(s) suspected as cause:
Cyclophosphamide
    Dosage: 1905 mg, unk
    Indication: Cord Blood Transplant Therapy
    Start date: 2012-01-05
    End date: 2012-01-06

Thymoglobulin
    Dosage: 476 mg, unk
    Indication: Cord Blood Transplant Therapy
    Start date: 2012-01-09
    End date: 2012-01-10

Targocid
    Dosage: 400 mg, 1x/day
    Start date: 2011-12-27
    End date: 2012-01-15

Neoral
    Dosage: unk
    Start date: 2011-10-29
    End date: 2012-01-15

Vfend
    Dosage: 400 mg, 1x/day
    Indication: Candidiasis
    Start date: 2011-12-30
    End date: 2012-01-15

Cefepime
    Dosage: 6 g, 1x/day
    Indication: Cord Blood Transplant Therapy
    Start date: 2011-12-30
    End date: 2012-01-15

Fludarabine
    Dosage: 68 mg, unk
    Indication: Cord Blood Transplant Therapy
    Start date: 2012-01-05
    End date: 2012-01-08



Possible Vfend side effects in male

Reported by a health professional (non-physician/pharmacist) from Japan on 2012-04-02

Patient: male, weighing 51.0 kg (112.2 pounds)

Reactions: Hepatic Function Abnormal, Renal Impairment, Pancytopenia

Adverse event resulted in: life threatening event, disablity

Drug(s) suspected as cause:
Fungizone
    Dosage: 50 mg, uid/qd
    Administration route: Topical
    Indication: Cranial Nerve Disorder
    Start date: 2011-01-13
    End date: 2011-01-13

Vfend
    Dosage: 220 mg, bid
    Indication: Cranial Nerve Disorder
    Start date: 2011-01-11
    End date: 2011-04-09

Vfend
    Dosage: 200 mg, bid
    Administration route: Oral
    Start date: 2011-04-10
    End date: 2011-05-16

Funguard
    Dosage: 150 mg, uid/qd
    Indication: Fungal Rhinitis
    Start date: 2010-12-18
    End date: 2011-04-12

Vfend
    Dosage: 300 mg, bid
    Indication: Systemic Mycosis
    Start date: 2010-11-17
    End date: 2010-11-25

Funguard
    Indication: Cranial Nerve Disorder

Fungizone
    Dosage: 50 mg, uid/qd
    Administration route: Topical
    Start date: 2011-01-20
    End date: 2011-01-20

Fungizone
    Dosage: 50 mg, uid/qd
    Administration route: Topical
    Start date: 2011-02-17
    End date: 2011-02-17

Ambisome
    Dosage: 120 mg, uid/qd
    Indication: Systemic Mycosis
    Start date: 2010-11-17
    End date: 2010-11-30

Ambisome
    Dosage: 165 mg, uid/qd
    Start date: 2010-12-01
    End date: 2010-12-10

Vfend
    Dosage: 200 mg, bid
    Start date: 2010-12-02
    End date: 2011-01-10

Vfend
    Dosage: 300 mg, bid
    Administration route: Oral
    Start date: 2011-04-09
    End date: 2011-04-09

Fungizone
    Dosage: 50 mg, uid/qd
    Administration route: Topical
    Start date: 2011-02-09
    End date: 2011-02-09

Fungizone
    Dosage: 50 mg, uid/qd
    Administration route: Topical
    Start date: 2011-02-03
    End date: 2011-02-03

Ambisome
    Dosage: 220 mg, uid/qd
    Indication: Cranial Nerve Disorder
    Start date: 2010-12-11
    End date: 2011-04-08

Funguard
    Indication: Systemic Mycosis

Fungizone
    Dosage: 50 mg, uid/qd
    Administration route: Topical
    Indication: Fungal Infection
    Start date: 2011-01-06
    End date: 2011-01-06

Other drugs received by patient: Epinastine Hydrochloride; Metformin HCL; Hydrocortisone Sodium Succinate; Humalog; Actos; Lantus; Meropenem; Kinedak



Possible Vfend side effects in female

Reported by a health professional (non-physician/pharmacist) from France on 2012-03-28

Patient: female

Reactions: Confusional State, Neurological Decompensation, Dyskinesia, Diplegia, Aphasia, Disorientation, Coma Scale Abnormal, Subdural Haemorrhage, Extensor Plantar Response, Speech Disorder, Hypotonia, Blood Creatinine Increased, Altered State of Consciousness

Adverse event resulted in: life threatening event

Drug(s) suspected as cause:
Neoral
    Dosage: unk ukn, unk
    Start date: 2011-10-29
    End date: 2012-01-15

Vfend
    Dosage: 400 mg, daily
    Start date: 2011-12-30
    End date: 2012-01-15

Targocid
    Dosage: 400 mg, daily
    Start date: 2011-12-27
    End date: 2012-01-15

Fludarabine Phosphate
    Dosage: unk ukn, unk
    Indication: Stem Cell Transplant
    Start date: 2012-01-05
    End date: 2012-01-08

Anti-Thymocyte Globulin Rabbit NOS
    Dosage: unk ukn, unk
    Start date: 2012-01-09
    End date: 2012-01-10

Cefepime
    Dosage: 6 g, daily
    Indication: Stem Cell Transplant
    Start date: 2011-12-30
    End date: 2012-01-15

Cyclophosphamide
    Dosage: 1905 mg, unk
    Indication: Stem Cell Transplant
    Start date: 2012-01-05
    End date: 2012-01-06

Other drugs received by patient: Corticosteroid NOS; Antilymphocyte Serum



Possible Vfend side effects in 28 year old female

Reported by a physician from France on 2012-03-07

Patient: 28 year old female, weighing 45.0 kg (99.0 pounds)

Reactions: Histiocytosis Haematophagic, Antibiotic Resistant Staphylococcus Test Positive, Clostridium Difficile Colitis, Toxic Epidermal Necrolysis, Eosinophilia, Pseudomonal Sepsis, Acute Respiratory Distress Syndrome, Oedema, Pneumococcal Sepsis

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Keppra
    Administration route: Oral
    Indication: Grand MAL Convulsion
    Start date: 2010-10-20
    End date: 2010-11-24

Flagyl
    Administration route: Oral
    Start date: 2010-11-10
    End date: 2010-11-16

Urbanyl
    Administration route: Oral
    Indication: Convulsion
    Start date: 2010-10-20
    End date: 2010-11-17

Vfend
    Administration route: Oral
    Indication: Ear Infection
    Start date: 2010-10-18
    End date: 2010-11-13

Other drugs received by patient: Cycloserine; Moxifloxacin; Kaletra; Ziagen; Ethambutol Hydrochloride; Viread; Para Aminosalicylic Acid; Prednisone TAB



Possible Vfend side effects in 28 year old female

Reported by a physician from France on 2012-03-05

Patient: 28 year old female, weighing 45.0 kg (99.0 pounds)

Reactions: Histiocytosis Haematophagic, Antibiotic Resistant Staphylococcus Test Positive, Toxic Epidermal Necrolysis, Clostridium Difficile Colitis, Eosinophilia, Pseudomonal Sepsis, Oedema, Acute Respiratory Distress Syndrome, Pneumococcal Sepsis

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Keppra
    Administration route: Oral
    Indication: Grand MAL Convulsion
    Start date: 2010-10-20
    End date: 2010-11-24

Urbanyl
    Administration route: Oral
    Indication: Convulsion
    Start date: 2010-10-20
    End date: 2010-11-17

Flagyl
    Administration route: Oral
    Start date: 2010-11-10
    End date: 2010-11-16

Vfend
    Administration route: Oral
    Indication: Ear Infection
    Start date: 2010-10-18
    End date: 2010-11-13

Other drugs received by patient: Moxifloxacin; Viread; Para Aminosalicylic Acid; Ziagen; Ethambutol Hydrochloride; Kaletra; Prednisone TAB; Cycloserine



Possible Vfend side effects in 69 year old female

Reported by a physician from Germany on 2012-02-29

Patient: 69 year old female, weighing 79.0 kg (173.8 pounds)

Reactions: Angiopathy

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Vfend



Possible Vfend side effects in 62 year old female

Reported by a health professional (non-physician/pharmacist) from France on 2012-02-28

Patient: 62 year old female

Reactions: Malaise, Disturbance in Attention, Hallucination

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Vfend

Other drugs received by patient: Atorvastatin; Solu-Medrol; Vitabact; Zovirax; Ciclosporin; Potassium Chloride; Vitamin B1 and B6; Sufentanil; Midazolam; Bactrim; Certican; Rocephin; Ciprofloxacin; Calcium Carbonate; Prednisone TAB; Folic Acid; Cancidas



Possible Vfend side effects in 58 year old male

Reported by a physician from Japan on 2012-02-24

Patient: 58 year old male

Reactions: Rhabdomyolysis

Adverse event resulted in: life threatening event

Drug(s) suspected as cause:
Vfend
    Dosage: 600 mg/day
    Administration route: Oral
    Indication: Bronchopulmonary Aspergillosis
    Start date: 2011-12-22
    End date: 2011-12-22

Vfend
    Dosage: 400 mg/day
    Administration route: Oral
    Start date: 2011-12-23
    End date: 2011-12-27

Other drugs received by patient: Micafungin Sodium; BIO Three; Allopurinol; Vancomycin; Rabeprazole Sodium



Possible Vfend side effects in male

Reported by a health professional (non-physician/pharmacist) from Japan on 2012-02-21

Patient: male, weighing 51.0 kg (112.2 pounds)

Reactions: Renal Impairment, Hepatic Function Abnormal, Pancytopenia

Adverse event resulted in: life threatening event

Drug(s) suspected as cause:
Vfend
    Dosage: 300 mg, bid
    Indication: Cranial Nerve Disorder
    Start date: 2010-11-17
    End date: 2010-11-25

Vfend
    Dosage: 200 mg, bid
    Administration route: Oral
    Start date: 2011-04-10
    End date: 2011-05-16

Vfend
    Dosage: 220 mg, bid
    Indication: Systemic Mycosis
    Start date: 2011-01-11
    End date: 2011-04-09

Fungizone
    Dosage: 50 mg, uid/qd
    Administration route: Topical
    Start date: 2011-01-20
    End date: 2011-01-20

Vfend
    Dosage: 300 mg, bid
    Administration route: Oral
    Start date: 2011-04-09
    End date: 2011-04-09

Funguard
    Dosage: 150 mg, uid/qd
    Indication: Fungal Rhinitis
    Start date: 2010-12-18
    End date: 2011-04-12

Fungizone
    Dosage: 50 mg, uid/qd
    Administration route: Topical
    Start date: 2011-02-09
    End date: 2011-02-09

Ambisome
    Dosage: 120 mg, uid/qd
    Start date: 2010-11-17
    End date: 2010-11-30

Fungizone
    Dosage: 50 mg, uid/qd
    Administration route: Topical
    Start date: 2011-01-06
    End date: 2011-01-06

Fungizone
    Dosage: 50 mg, uid/qd
    Administration route: Topical
    Start date: 2011-01-13
    End date: 2011-01-13

Ambisome
    Dosage: 220 mg, uid/qd
    Indication: Systemic Mycosis
    Start date: 2010-12-11
    End date: 2011-04-08

Fungizone
    Dosage: 50 mg, uid/qd
    Administration route: Topical
    Start date: 2011-02-03
    End date: 2011-02-03

Ambisome
    Dosage: 165 mg, uid/qd
    Start date: 2010-12-01
    End date: 2010-12-10

Vfend
    Dosage: 200 mg, bid
    Start date: 2010-12-02
    End date: 2011-01-10

Fungizone
    Dosage: 50 mg, uid/qd
    Indication: Fungal Infection
    Start date: 2011-02-17
    End date: 2011-02-17

Other drugs received by patient: Lantus; Humalog; Hydrocortisone Sodium Succinate; Metformin HCL; Actos; Epinastine Hydrochloride; Meropenem; Kinedak



 Page 1   Next >>

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2014